Loews Other Non-Current Liabilities decreased by 2.8% to $4.38B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.0%, from $4.47B to $4.38B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows relatively stable performance with a -0.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.70B | $4.68B | $4.53B | $4.31B | $4.49B | $4.51B | $4.28B | $4.04B | $4.19B | $4.41B | $4.30B | $4.31B | $4.44B | $4.41B | $4.39B | $4.47B | $4.48B | $4.36B | $4.51B | $4.38B |
| QoQ Change | — | -0.4% | -3.2% | -4.9% | +4.2% | +0.5% | -5.0% | -5.7% | +3.8% | +5.1% | -2.4% | +0.2% | +2.9% | -0.6% | -0.4% | +1.7% | +0.4% | -2.7% | +3.3% | -2.8% |
| YoY Change | — | — | — | — | -4.5% | -3.6% | -5.4% | -6.2% | -6.5% | -2.3% | +0.4% | +6.7% | +5.8% | +0.1% | +2.1% | +3.6% | +1.0% | -1.1% | +2.6% | -2.0% |